PolyPid Appoints Brooke Story as New Chairman
Ticker: PYPD · Form: 6-K · Filed: Dec 16, 2025 · CIK: 1611842
| Field | Detail |
|---|---|
| Company | Polypid Ltd. (PYPD) |
| Form Type | 6-K |
| Filed Date | Dec 16, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment
Related Tickers: BDX
TL;DR
PolyPid names Brooke Story, ex-BD exec, as new Chairman effective Dec 11.
AI Summary
PolyPid Ltd. announced on December 16, 2025, the appointment of Brooke Story as a director and chairman of its Board of Directors, effective December 11, 2025. Ms. Story, 54, previously led the separation and integration management office at Becton, Dickinson and Company (BD) since June 2024 and held the position of Worldwide President, Surgery, at BD from July 2023 to March 2024.
Why It Matters
The appointment of a new chairman with experience at a major medical device company like BD could signal strategic shifts or enhanced operational focus for PolyPid.
Risk Assessment
Risk Level: low — This filing is a routine corporate announcement regarding board appointments and does not involve financial performance or significant operational changes.
Key Players & Entities
- PolyPid Ltd. (company) — Company making the announcement
- Brooke Story (person) — Newly appointed director and chairman
- December 16, 2025 (date) — Date of announcement
- December 11, 2025 (date) — Effective date of appointment
- Becton, Dickinson and Company (company) — Previous employer of Brooke Story
- BD (company) — Abbreviation for Becton, Dickinson and Company
- NYSE:BDX (company) — Stock ticker for Becton, Dickinson and Company
- June 2024 (date) — Start date of Brooke Story's role at BD
- July 2023 (date) — Start date of Brooke Story's role as Worldwide President, Surgery at BD
- March 2024 (date) — End date of Brooke Story's role as Worldwide President, Surgery at BD
FAQ
Who is Brooke Story and what is her background?
Brooke Story is 54 years old and has been appointed as a director and chairman of PolyPid Ltd.'s Board of Directors. Her prior experience includes leading the separation and integration management office at Becton, Dickinson and Company (BD) since June 2024, and serving as Worldwide President, Surgery, at BD from July 2023 to March 2024.
When was Brooke Story's appointment effective?
Brooke Story's appointment as director and chairman of PolyPid Ltd.'s Board of Directors was effective December 11, 2025.
What is the filing type and date?
This is a Form 6-K filing, reported as Report No. 2 for the month of December 2025, filed on December 16, 2025.
What is PolyPid Ltd.'s primary business?
PolyPid Ltd. is classified under Standard Industrial Classification code 3841, which pertains to Surgical & Medical Instruments & Apparatus.
What is the company's principal executive office address?
The company's principal executive office is located at 18 Hasivim Street, Petach Tikva 495376, Israel.
Filing Stats: 572 words · 2 min read · ~2 pages · Grade level 8.6 · Accepted 2025-12-16 08:35:12
Filing Documents
- ea0269841-6k_polypid.htm (6-K) — 15KB
- ea026984101ex99-1_polypid.htm (EX-99.1) — 11KB
- 0001213900-25-121938.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. POLYPID LTD. Date: December 16, 2025 By: /s/ Dikla Czaczkes Akselbrad Name: Dikla Czaczkes Akselbrad Title: Chief Executive Officer 3